Product
IAP0971＋BCG
1 clinical trial
1 indication
Indication
Bladder CancerClinical trial
A Phase I/II Clincal Trial of Intravesical IAP0971 in Combination With Bacillus Calmette Guerin (BCG) in Patients With BCG Unresponsive High Risk Non-Muscular Invasive Bladder Cancer (NMIBC)Status: Not yet recruiting, Estimated PCD: 2024-10-07